256 related articles for article (PubMed ID: 6977039)
1. Involvement of fibronectin, Von Willebrand factor, and fibrinogen in platelet interaction with solid substrata.
Lahav J; Hynes RO
J Supramol Struct Cell Biochem; 1981; 17(4):299-311. PubMed ID: 6977039
[TBL] [Abstract][Full Text] [Related]
2. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
3. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
4. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
Li X; Gabriel DA
Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
[TBL] [Abstract][Full Text] [Related]
5. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
Olson JD; Zaleski A; Herrmann D; Flood PA
J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
[TBL] [Abstract][Full Text] [Related]
6. Platelet adhesion.
Packham MA; Mustard JF
Prog Hemost Thromb; 1984; 7():211-88. PubMed ID: 6397767
[TBL] [Abstract][Full Text] [Related]
7. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of plasmin-induced aggregation of human platelets: implication of secreted von Willebrand factor.
Rabhi-Sabile S; de Romeuf C; Pidard D
Thromb Haemost; 1998 Jun; 79(6):1191-8. PubMed ID: 9657447
[TBL] [Abstract][Full Text] [Related]
9. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
[TBL] [Abstract][Full Text] [Related]
10. Platelet adhesion to collagen type I, collagen type IV, von Willebrand factor, fibronectin, laminin and fibrinogen: rapid kinetics under shear.
Polanowska-Grabowska R; Simon CG; Gear AR
Thromb Haemost; 1999 Jan; 81(1):118-23. PubMed ID: 10348702
[TBL] [Abstract][Full Text] [Related]
11. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
12. Multiple platelet surface receptors mediate platelet adhesion to surfaces coated with plasma proteins.
DiFazio LT; Stratoulias C; Greco RS; Haimovich B
J Surg Res; 1994 Jul; 57(1):133-7. PubMed ID: 8041127
[TBL] [Abstract][Full Text] [Related]
13. Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading.
Bolhuis PA; Sakariassen KS; Sander HJ; Bouma BN; Sixma JJ
J Lab Clin Med; 1981 Apr; 97(4):568-76. PubMed ID: 6782184
[TBL] [Abstract][Full Text] [Related]
14. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen and von Willebrand factor mediated platelet adhesion to polystyrene under flow conditions.
Zhang M; Wu Y; Hauch K; Horbett TA
J Biomater Sci Polym Ed; 2008; 19(10):1383-410. PubMed ID: 18854129
[TBL] [Abstract][Full Text] [Related]
16. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
18. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
[TBL] [Abstract][Full Text] [Related]
19. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP
Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386
[TBL] [Abstract][Full Text] [Related]
20. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
